These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 2650111)

  • 1. Allogeneic lymphocytes are rejected in hyperacute fashion by enhanced rats bearing a heart allograft from the same donor.
    Olszewski WL; Orlewska E; Ryffa T
    Transplant Proc; 1989 Feb; 21(1 Pt 1):244-5. PubMed ID: 2650111
    [No Abstract]   [Full Text] [Related]  

  • 2. Allogeneic lymphocytes are rejected by DST-pretreated, CyA-treated rats with accepted heart allograft from the same donor in a hyperacute fashion.
    Olszewski WL; Orlewska E; Ryffa T; Podgorska D
    Transplant Proc; 1990 Aug; 22(4):1985-6. PubMed ID: 2389503
    [No Abstract]   [Full Text] [Related]  

  • 3. Donor-specific transfusion does not mitigate but accelerates rejection of intravenously transplanted lymphocytes.
    Jaskłowska-Englisz M; Podgórska D; Adamczyk G; Olszewski WL
    Arch Immunol Ther Exp (Warsz); 1993; 41(5-6):365-71. PubMed ID: 8010878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rejection of allogeneic lymphocytes and heart allografts from the same donor is mediated by different mechanisms.
    Orlewska E; Olszewski WL
    Transplant Proc; 1987 Feb; 19(1 Pt 1):437-8. PubMed ID: 3274800
    [No Abstract]   [Full Text] [Related]  

  • 5. Donor-specific transfusions prolong heart allograft survival but lymphocytes from the same donor are acutely rejected.
    Jaskłowska-Englisz M; Olszewski WL
    Transplant Proc; 1994 Dec; 26(6):3463. PubMed ID: 7998224
    [No Abstract]   [Full Text] [Related]  

  • 6. Allogeneic lymphocyte cytotoxicity. Evidence that target cells include most, if not all, donor lymphocytes.
    Ford WL; Heslop BF
    Transplantation; 1987 May; 43(5):753-7. PubMed ID: 3576680
    [No Abstract]   [Full Text] [Related]  

  • 7. Immune mechanisms in organ allograft rejection. V. Pivotal role of the cytotoxic-suppressor T cell subset in the rejection of heart grafts bearing isolated class I disparities in the inbred rat.
    Lowry RP; Forbes RD; Blackburn JH; Marghesco DM
    Transplantation; 1985 Nov; 40(5):545-50. PubMed ID: 3904091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporine control of recipient lymphocyte traffic to the heart allograft.
    Maksymowicz M; Olszewski WL
    Transplant Proc; 1996 Dec; 28(6):3441-3. PubMed ID: 8962342
    [No Abstract]   [Full Text] [Related]  

  • 9. Humoral immunity in allograft rejection. The role of cytotoxic alloantibody in hyperacute rejection and enhancement of rat cardiac allografts.
    Oluwole SF; Tezuka K; Wasfie T; Stegall MD; Reemtsma K; Hardy MA
    Transplantation; 1989 Nov; 48(5):751-5. PubMed ID: 2815247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrathymic injection of alloantigen may lead to hyperacute rejection and prolonged graft survival of heart allografts in the rat.
    de Bruin RW; van Rossum TJ; Scheringa M; Bonthuis F; IJzermans JN; Marquet RL
    Transplantation; 1995 Nov; 60(9):1061-3. PubMed ID: 7491686
    [No Abstract]   [Full Text] [Related]  

  • 11. Specific immunosuppression of cardiac allograft rejection in rats.
    Jenkins AM; Woodruff MF
    Transplant Proc; 1973 Mar; 5(1):727-32. PubMed ID: 4144462
    [No Abstract]   [Full Text] [Related]  

  • 12. A comparison of 51chromium and Hoechst 33342 for monitoring lymphocyte migration in vivo.
    Cranston D; Wood KJ; Morris PJ
    Transplant Proc; 1989 Feb; 21(1 Pt 1):192-3. PubMed ID: 2468214
    [No Abstract]   [Full Text] [Related]  

  • 13. Mechanisms of cardiac allograft rejection in the inbred rat: the effect of complement depletion by cobra venom factor on hyperacute cardiac allograft rejection.
    Whittum JA; Lindquist RR
    Transplantation; 1977 Sep; 24(3):226-8. PubMed ID: 339433
    [No Abstract]   [Full Text] [Related]  

  • 14. Graft-versus-host and cytotoxic activity of rat thoracic duct lymphocytes fractionated by zonal centrifugation after culture on allogeneic fibroblasts.
    Bowers WE
    J Immunol; 1974 Oct; 113(4):1252-61. PubMed ID: 4153365
    [No Abstract]   [Full Text] [Related]  

  • 15. Peptides derived from alpha-helices of allogeneic class I major histocompatibility complex antigens are potent inducers of CD4+ and CD8+ T cell and B cell responses after cardiac allograft rejection.
    Shirwan H; Leamer M; Wang HK; Makowka L; Cramer DV
    Transplantation; 1995 Feb; 59(3):401-10. PubMed ID: 7871571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of brequinar sodium on accelerated cardiac allograft rejection in presensitized recipients.
    Nozaki S; Ito T; Kamiike W; Uchikoshi F; Yamamoto S; Nakata S; Shirakura R; Miyata M; Matsuda H; Stepkowski SM
    Transplant Proc; 1994 Aug; 26(4):2333-5. PubMed ID: 7520633
    [No Abstract]   [Full Text] [Related]  

  • 17. Cyclosporin therapy for treatment of rat heart allograft rejection.
    Westra AL; Petersen AH; Prop J; Wildevuur CR
    Transplant Proc; 1989 Feb; 21(1 Pt 1):963-4. PubMed ID: 2650301
    [No Abstract]   [Full Text] [Related]  

  • 18. Elucidation of rejection mechanisms using the splenocyte injection model in concordant xenotransplantation.
    Yasutomi M; Hayashi S; Ohtsuka S; Namii Y; Ito M; Uchida K; Yokoyama I; Takagi H
    Transplant Proc; 1995 Apr; 27(2):1583-4. PubMed ID: 7725417
    [No Abstract]   [Full Text] [Related]  

  • 19. Modified graft rejection by transfusion of the donor: a role for dendritic cells.
    Heineman E; Bouwman E; Marquet RL; Jeekel J
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1470-2. PubMed ID: 3274358
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunological detection of rat heart allograft rejection.
    Ono K; Hornung MO; McDonald JC
    Transplantation; 1972 Jul; 14(1):137-40. PubMed ID: 4556399
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.